Product Recalls in Indiana

Product recalls affecting Indiana — including food, drugs, consumer products, medical devices, and vehicles distributed to Indiana. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,747 recalls have been distributed to Indiana in the last 12 months.

53,528 total recalls
2,747 in last 12 months

Showing 50415060 of 13,412 recalls

DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Cool Mint Tablets Maximum Strength Zantac 150 mg Sanofi Distributed by:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Maximum Strength Zantac 150 mg Distributed by: Chattem Recalled by...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Maximum Strength Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Cool Mint Maximum Strength Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Regular Strength Zantac 150 mg Recalled by Sanofi-Aventis U.S. LLC Due to...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Sanofi-Aventis U.S. LLC

Recalled Item: Zantac 75 mg Recalled by Sanofi-Aventis U.S. LLC Due to CGMP Deviations:...

The Issue: CGMP Deviations: Presence of NDMA impurity detected in product.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 22, 2019· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Estradiol Vaginal Inserts USP Recalled by Glenmark Pharmaceuticals Inc., USA...

The Issue: Defective Delivery System: complaints for difficulty in pushing the plunger...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 21, 2019· Nephron Pharmaceuticals Corporation dba Nephron Sterile Compounding Center

Recalled Item: PF-Succinylcholine Chloride Injection Recalled by Nephron Pharmaceuticals...

The Issue: Incorrect labeling: Incorrect or missing lot and/or exp date

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 18, 2019· Mylan Pharmaceuticals Inc.

Recalled Item: Prasugrel Tablets 5 mg Recalled by Mylan Pharmaceuticals Inc. Due to Failed...

The Issue: Failed Dissolution Specification: Low out of specification dissolution results.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 17, 2019· Sandoz Inc

Recalled Item: Gatifloxacin Ophthalmic Solution 0.5% Recalled by Sandoz Inc Due to...

The Issue: Labeling: Incorrect or missing package insert.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 17, 2019· Sandoz Inc

Recalled Item: Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension...

The Issue: Labeling: Incorrect or missing package insert.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 17, 2019· Sandoz Inc

Recalled Item: Bimatoprost Ophthalmic Solution 0.03% Recalled by Sandoz Inc Due to...

The Issue: Labeling: Incorrect or missing package insert.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugOctober 15, 2019· 8046255 Canada Inc. DBA Viatrexx

Recalled Item: Viatrexx-Neuro 3 Recalled by 8046255 Canada Inc. DBA Viatrexx Due to Lack of...

The Issue: Lack of Assurance of Sterility: products manufactured in a manner than...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 15, 2019· 8046255 Canada Inc. DBA Viatrexx

Recalled Item: Viatrexx-Articula Recalled by 8046255 Canada Inc. DBA Viatrexx Due to Lack...

The Issue: Lack of Assurance of Sterility: products manufactured in a manner than...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugOctober 15, 2019· 8046255 Canada Inc. DBA Viatrexx

Recalled Item: Viatrexx-Male+ Recalled by 8046255 Canada Inc. DBA Viatrexx Due to Lack of...

The Issue: Lack of Assurance of Sterility: products manufactured in a manner than...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund